Sandra Coufal

Sibling Capital LLC (Sibling Capital) is a private equity firm founded in 2012 by Sandra I. Coufal and Brian M. Isern. The firm is headquartered in Santa Fe, California.

Relypsa, Inc. operates as a bio-pharmaceutical company, which engages in the development and commercialization of late-stage medicines in the iron deficiency, nephrology, and cardio-renal therapeutic areas. It offers Veltassa, a potassium binder approved for the treatment of hyperkalemia. The company was founded by Jerry M. Buysse, Gerrit Klaerner, Michael Burdick, Jay P. Shepard, Detlef F. Albrecht, George Tyson, Sandra I. Coufal and Vic Ciaravino on October 29, 2007 and is headquartered in Redwood City, CA.

Ilypsa, Inc. operates a biopharmaceutical firm. It develops renal care pharmaceutical products. The company was founded on March 6, 2003 and is headquartered in Thousand Oaks, CA.

Safety Spot, Inc. develops a web-based platform for training, consumables, scheduling, maintenance, and asset management in organizations. It allows users to create organization and accounts for personnel, visitors, and contractors; update organization’s emergency info, sites, assets, systems, and trainings. The company was founded by Diego Diaz and Brandon Iglesias and is headquartered in Los Angeles, CA.

Bioaesthetics Corp. provides biotechnology health care services. The company was founded by Nicholas C. Pashos and is headquartered in New Orleans, LA.

Scripps Green Hospital operates as a hospital. The private company is based in La Jolla, CA.

Toragen, Inc. is a clinical-stage biotechnology company that is focused on developing treatments for HPV-induced cancers, starting with head and neck cancer. Toragen is based in San Diego, CA. The company is targeting the root cause of virally induced cancers. The company was founded by Andrew Sharabi and the CEO is Sandra I. Coufal.